Patents by Inventor Richard S. Lehner

Richard S. Lehner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6825327
    Abstract: The invention relates to processes for preparing compounds of formula 1 wherein R3 is as defined herein, and to pharmaceutically acceptable salts thereof, as well as intermediates useful in such processes. The compounds of formula 1 are antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to pharmaceutical compositions containing compounds prepared by the processes of the invention and to methods of treating bacterial protozoa infections by administering such compounds.
    Type: Grant
    Filed: April 25, 2002
    Date of Patent: November 30, 2004
    Assignee: Pfizer Inc.
    Inventors: Constantine Sklavounos, John L. Tucker, Lulin Wei, Kerry P. Mahon, Philip Hammen, Joanna T. Negri, Richard S. Lehner
  • Publication number: 20030064939
    Abstract: The invention relates to processes for preparing compounds of formula 1 1
    Type: Application
    Filed: April 25, 2002
    Publication date: April 3, 2003
    Inventors: Constantine Sklavounos, John L. Tucker, Lulin Wei, Kerry P. Mahon, Philip Hammen, Joanna T. Negri, Richard S. Lehner
  • Patent number: 6476040
    Abstract: The present invention relates to methods and intermediates for preparing compounds of the formula 1 and the pharmaceutically acceptable salts and solvates thereof, as well as structurally related compounds, wherein R1, R2 and R15 are as defined herein. The foregoing compounds are useful in the treatment of hyperproliferative disorders, such as cancers, in mammals.
    Type: Grant
    Filed: March 30, 2000
    Date of Patent: November 5, 2002
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Timothy Norris, Dinos P. Santafianos, Richard S. Lehner
  • Patent number: 5380860
    Abstract: A method for preparing a compound of the formula ##STR1## wherein Q is C--H or N; R.sup.1 is C.sub.1-C.sub.4 alkyl, benzyl or p-nitrobenzyl and X and Y are independently selected from fluoro and chloro comprising reacting a compound of the formula ##STR2## wherein Q is >C--H or N; X and Y are independently selected from fluoro and chloro; and Z is fluoro, chloro, 1-imidazolyl or substituted 1-imidazolyl, wherein the 1-imidazolyl group is substituted with one or two substituents independently selected from C.sub.1 to C.sub.4 alkyl, with a compound of the formula[M.sup.n+ ].sub.p [V.sup.p- ].sub.nwherein M is an alkaline earth metal, Cu or Mn, n is 2, V.sup.p-, wherein p is 1 or 2, is an anion of the formula ##STR3## or a dianion of the formula ##STR4## and R.sup.1 is C.sub.1 to C.sub.6 alkyl or paranitrobenzyl, with the proviso that when Z is 1-imidazolyl or substituted 1-imidazole, M is magnesium, copper or manganese and with the proviso that when Z is fluoro, chloro or bromo, V.sup.
    Type: Grant
    Filed: January 24, 1992
    Date of Patent: January 10, 1995
    Assignee: Pfizer Inc.
    Inventors: Frank R. Busch, Richard S. Lehner, Brian T. O'Neill